GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel

Filters
List of articles in category GlaxoSmithKline
Title Published Date
GlaxoSmithKline update: A (H1N1) influenza vaccine development 18 May 2009
GlaxoSmithKline update: influenza A (H1N1) 06 May 2009
Emergence of a new H1N1 influenza A strain (swine influenza) 30 April 2009
OTC weight loss aid is available in pharmacies across Europe 21 April 2009
GSK submits Tyverb®/Tykerb® for first-line treatment of metastatic breast cancer in Europe, US 02 April 2009
NICE refuses funding for advanced breast cancer treatment, Tyverb® 05 March 2009
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ 05 February 2009
GSK to drive growth in emerging markets with acquisition of UCB products 24 January 2009
GSK and Neptunus form joint venture for the co-development of flu vaccines 24 November 2008
GSK’s Emerging Markets strategy advances with acquisition in Egypt 20 October 2008
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement 29 August 2008
GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration 29 July 2008